Post-transplant Lymphoproliferative Disorder (PTLD): Infection, Cancer?

被引：0
|
作者：
Voorhees T.J. [1 ]
Baiocchi R.A. [1 ,2 ]
机构：
[1] Department of Internal Medicine, Division of Hematology, Ohio State University College of Medicine, 460 West 10th Avenue, Columbus, 43210, OH
[2] Division of Hematology, The Ohio State University, 320 West 10th Avenue, Columbus, 43210, OH
来源：
Current Transplantation Reports | 2016年 / 3卷 / 2期
关键词：
EBV; EBV oncogenesis; EBV transformation; Post-transplant lymphoproliferative disorder;
D O I：
10.1007/s40472-016-0102-0
中图分类号：
学科分类号：
摘要：
Post-transplant lymphoproliferative disorder encompasses a broad spectrum of lymphoid disorders that occur in immune-suppressed patients following solid or hematopoietic stem cell transplantation. The Epstein-Barr virus (EBV) is an oncogenic virus capable of transforming B lymphocytes and is associated with the pathogenesis of multiple benign and malignant lymphoproliferative disorders, including PTLD. This review outlines current knowledge of EBV pathogenesis, its role in B cell immortalization, transformation, and as an etiologic agent in lymphoproliferative disorders in immune-suppressed patients following transplantation. Here, we provide discussion incorporating infectious disease and medical oncology aspects. © 2016, Springer International Publishing AG.
引用
收藏
页码：145 / 153
页数：8
相关论文
共 50 条
  • [1] Post-transplant lymphoproliferative disorder (PTLD)
    Petrik, D. W.
    Lai, R.
    Pearcey, R. G.
    CLINICAL ONCOLOGY, 2007, 19 (02) : 163 - 164
  • [2] Cytogenetic abnormalities in post-transplant lymphoproliferative disorder (PTLD)
    Djokic, M
    Liebowitz, D
    Lebeau, M
    Anastasi, J
    Carlson, K
    LABORATORY INVESTIGATION, 2003, 83 (01) : 230A - 230A
  • [3] Cytogenetic abnormalities in post-transplant lymphoproliferative disorder (PTLD)
    Djokic, M
    Liebowitz, D
    LeBeau, MM
    Anastasi, J
    Carlson, K
    MODERN PATHOLOGY, 2003, 16 (01) : 230A - 230A
  • [4] Post-Transplant Lymphoproliferative Disorder (PTLD) in Kidney Transplant (KTx) Recipients
    Zhang, Pingchuan
    King, Rebecca
    Ristow, Kay M.
    Cosio, Fernando
    Cornell, Lynn D.
    Habermann, Thomas M.
    Alexander, Mariam P.
    LABORATORY INVESTIGATION, 2017, 97 : 412A - 412A
  • [5] Post-Transplant Lymphoproliferative Disorder (PTLD) in Kidney Transplant (KTx) Recipients
    Zhang, Pingchuan
    King, Rebecca
    Ristow, Kay M.
    Cosio, Fernando
    Cornell, Lynn D.
    Habermann, Thomas M.
    Alexander, Mariam P.
    MODERN PATHOLOGY, 2017, 30 : 412A - 412A
  • [6] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) MASQUERADING AS ACUTE REJECTION
    Abdulrazzak, Ameer
    Butcher, David B.
    Bellovich, Keith A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A19 - A19
  • [7] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) IN RENAL-ALLOGRAFTS
    BRANCAZIO, L
    BANNER, B
    HAKALA, T
    NALESNIK, M
    LABORATORY INVESTIGATION, 1989, 60 (01) : A12 - A12
  • [8] DELAYED PRIMARY CNS POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD)
    Chhetri, S. K.
    Dayanandan, R.
    Joseph, J.
    Armour, A.
    Sonwalkar, H.
    Emsley, H. C. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03):
  • [9] Treatment for renal post-transplant lymphoproliferative disorder (PTLD) with rituximab
    Berthou, J.
    Nerich, V.
    Fagnoni-Legat, C.
    Bittard, H.
    Chalopin, J. M.
    Limat, S.
    PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 1015 - 1015
  • [10] EBV-induced post-transplant lymphoproliferative disorder (PTLD)
    Birkeland, SA
    HamiltonDutoit, S
    Sandvej, K
    Andersen, HMK
    Bendtzen, K
    Moller, B
    Jorgensen, KA
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3467 - 3472
12345